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Abstract
CD1a autoreactive T cells are common in human blood and skin, but the search for natural
autoantigens has been confounded by background T cell responses to CD1 proteins and self lipids.
After capturing CD1a-lipid complexes, we gently eluted ligands, while preserving unliganded
CD1a for testing lipids from tissues. CD1a released hundreds of ligands of two types. Inhibitory
ligands were ubiquitous membrane lipids with polar headgroups, whereas stimulatory compounds
were apolar oils. CD1a autoantigens naturally accumulate in epidermis and sebum, where they
were identified as squalene and skin waxes. T cell activation by skin oils suggests that headless
mini-antigens nest within CD1a and displace non-antigenic resident lipids with large head groups.
Oily autoantigens naturally coat the skin's surface, pointing to a new mechanism of barrier
immunity.
Introduction
T cell autoreactivity to CD1 was first described for an αβ T cell clone recognizing CD1a1,
leading to a search for self-antigens that might bind to CD1 proteins. Although most
research has focused on CD1d and NKT cells, recent studies that measure T cell
autoreactivity to each type of human CD1 antigen presenting molecule have identified the
highest rates of recognition of CD1a or CD1c2,3. CD1a- or CD1c-autoreactive cells infiltrate
thyroid glands in autoimmune disease4. Also, human CD1a-autoreactive T cells in the blood
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texpress cutaneous lymphocyte antigen, CCR4, CCR6, CCR10, which mediate migration to
skin2. Colocalization of CD1a-expressing Langerhans cells (LCs) and CD1a autoreactive T
cells suggest basic roles for CD1a in skin immunity5.
Mammalian lipids that stimulate autoreactive T cells have been identified 6–10. Many of
these lipids were selected for study because they mimic foreign α-galactosyl ceramide
antigens for NKT cells7,8,10, whereas others were pre-selected and then used to expand
populations of T cells through repeated in vitro immunization6,11. An approach using
unimmunized T cells to analyze the many types of endogenous lipids expressed in the
tissues where T cells reside is desirable because this discovery process is unbiased and
focuses on natural antigens. However, endogenous antigens within antigen presenting cells
(APCs) cause background T cell activation that masks T cell response to added lipids in
reconstitution assays. Here we used several techniques to defeat such background signals
and identified oily autoantigens that lack carbohydrate or charged headgroups. Discovery of
antigens lacking polar headgroups was unexpected because known antigens presented by
MHC12,13 and CD114 use hydrogen bonding and ionic interactions to bind TCRs. Lacking
any precedent for TCR recognition of oils, we used structure-function assays and analysis of
hundreds of ligands released from CD1a proteins to identify general patterns of antigens that
stimulated CD1a autoreactivity. Whereas lipids with hydrophilic headgroups were
inhibitory, several lipids lacking headgroups stimulated T cells. We proposed that small,
headless molecules nest within the CD1 groove are recognized based on non-interference of
TCR contact with CD1.
Results
Polyclonal T cells show autoreactivity to CD1a
Recently developed methods measure autoreactivity of T cells to CD1a, CD1b, CD1c and
CD1d using CD1 transfected K562 cells2. These MHClow cells function as universal APCs
that bypass alloreactivity and detect polyclonal CD1 autoreactive cells ex vivo in any donor.
In agreement with our prior study of 14 donors using interferon-γ (IFN-γ) as a readout2, we
detected high rates of CD1a autoreactivity in a new analysis of short term T cell lines using
IL-2 release. CD1a+ APCs generated detectable autoreactivity in 8 out of 10 patients. As
compared to other CD1 isoforms, CD1a generated the highest responses in 7 of 10 donors
(Fig.1a). These results, along with evidence that CD1a autoreactive cells can comprise up to
10 percent of all T cells3, prompted us to focus on autoantigen discovery in the CD1a
system, as the most prominent source of CD1 autoreactive T cells in human blood. We
derived and named 5 T cell lines (BC2, DermT, BC5, Bgp, BC14) whose activation was
inhibited by anti-CD1a blocking antibody (OKT6), confirming that the response was
dependent on CD1a and not on other cell surface determinants (Fig. 1b).
Isolation of antigenic CD1a complexes from cells
If autoantigens are present in the APCs, CD1 autoreactive T cells show baseline reactivity,
which masks responses to any added antigen used in reconstitution assays. Background
signals have been a major impediment to discovery of endogenous autoantigens, but might
be overcome by dissociating CD1 proteins from the cells that produce them and stripping
proteins of endogenously loaded ligands. Also, lipids eluting from CD1a proteins might
reflect the types of lipids normally loaded onto CD1 proteins in cells, allowing identification
of both non-stimulatory ligands and stimulatory autoantigens. Taking advantage of
constructs previously designed for other CD1 proteins, we produced transmembrane-
truncated, biotinylated CD1a proteins zippered to β-2 microglobulin (β2M) with high yields
in HEK293 cells15,16 (Fig. 2a). These proteins showed the expected apparent mass and were
pulled down by streptavidin beads (Fig. 2a). When bound to a plate, cell-derived CD1a
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tactivated the CD1a-autoreactive T cell line BC2 (Fig. 2b). Thus the recombinant CD1a
proteins retained the structures needed for activating T cells, creating an APC-free system
for identifying antigens.
CD1a autoreactivity might occur due to TCR contact with unliganded CD1 proteins or CD1
proteins bound to ubiquitous self-molecules17. Dideoxymycobactin (DDM) is CD1a ligand
that is known to bind within the A' and F' pockets of the groove18 and to activate the T cell
line CD8-219. DDM suppressed BC2 activation in a dose-dependent fashion. Because
culture wells were washed after adding lipid but before adding T cells, inhibition was
unlikely due to non-specific effects of lipid on T cells. Lack of toxicity was further
supported when DDM activated CD8-2 over the same dose range at which inhibition of BC2
was seen (Fig. 2c). Thus, BC2 activation likely involved the distal surface of CD1a near the
groove portal, where DDM binds. However, whether DDM displaced an antigenic self-
compound or inserted into the groove to block TCR contact with the previously unliganded
CD1a remained unresolved.
Unloading of ligands occurs over a pH range of 6.5 to 4, which represents conditions that do
not induce irreversible unfolding of CD1a proteins20. Brief pretreatment of plate-bound
CD1a proteins with acidic pH (Supplementary Fig. 1), followed by washing at neutral pH,
diminished CD1a stimulation of BC2, suggesting that ligand loss abrogated T cell
activation, pointing away from direct recognition of unliganded CD1a proteins as the
mechanism of T cell activation. By producing CD1a and MHC class I proteins in high yield,
eluting ligands under mildly acidic conditions and applying concentrated eluents to pre-
stripped CD1a proteins, we could demonstrate transfer of stimulatory substances from CD1a
to CD1a but not MHC class I to CD1a (Fig. 2d). Thus, endogenous autoantigens exist and
are loaded onto CD1a proteins by the cells that produce them.
Cellular CD1a protein complexes bind the T cell receptor (TCR)
To understand the basis of BC2 TCR autoreactivity towards CD1a, we expressed the
ectodomains of the BC2 TCR α and β chains and measured the affinity of the BC2 TCR
towards to the U293-derived truncated CD1 proteins using surface plasmon resonance
(SPR). The autoreactive BC2 TCR bound to CD1a proteins derived from cells (Fig. 2e) with
an affinity value (Kd = 92.7 ± 5.3 μM) that is comparable to that seen in autoreactive TCR-
peptide-MHC interactions21. Thus, the BC2 TCR can bind to cellular CD1a complexes.
CD1a releases chemically diverse cellular ligands
Next, we attempted to identify both antigenic and non-antigenic ligands that eluted from
CD1a in chloroform and methanol. Prior studies of CD1d22,23, CD1c24 and CD1b25
identified large numbers of lipid ligands binding to CD1 proteins. However, the identity of
CD1a ligands was unknown. Transmembrane truncation can influence some lipids bound to
CD1d proteins23 and necessarily removes cytoplasmic sequences with tail motifs that
mediate recycling to endosomes. However, human CD1a lacks recycling motifs26, so would
be expected to mimic non-recycled full length CD1a, as supported by a detailed study
comparing native and tail-truncated truncated CD1a proteins27. Analysis of eluents using
sensitive methods of nanoelectrospray infusion mass spectrometry detected more than one
hundred distinct ions with m/z values between 700 and 1500, indicating that many self-
molecules bind to CD1a (Fig. 3a). Focusing on intense ions in the positive mode, collision-
induced dissociation mass spectrometry (CID-MS) identified four types of sphingolipid
ligands: sphingomyelin, trihexosylceramide, ganglioside GM3 and globoside Gb4. In
addition, we detected trace signals for triacylglyceride TAG (Fig. 3a and Supplementary Fig.
2). In negative mode analysis, we identified five classes of phosphatidic acid containing
compounds: phosphatidylinositol (PI), phosphatidylethanolamine (PE), phosphatidylglycerol
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t(PG), phosphatidylserine (PS), and phosphatidylcholine (PC) (Fig. 3a and Supplementary
Fig. 3). Within each class we detected a range of molecular variants that differ in chain
length and unsaturation. Overall, CD1a proteins normally bind a broad range of molecules
that differ in the nature of their hydrophilic head groups, which can contain carbohydrates,
charged atoms, or in the case of TAG, lack polar head groups.
To better quantitate the molecular heterogeneity of CD1a ligands, we took advantage of a
recently developed lipidomics platform25,28 which detected 1,336 molecular events. In the
normal phase, retention time correlates with polarity. Using named molecules within this
dataset (TAG, DAG, PE, SM) as benchmarks, we classified CD1a eluted molecular events
into 3 groups based on retention time. CD1a ligands distribute somewhat evenly into groups
described as having low (22%), intermediate (31%) or high (47 %) polarity (Fig. 3c). Thus,
truncated CD1a proteins egressing through the secretory pathway normally bind hundreds of
distinct ligands that span a broad spectrum of polarity.
Triacylglyceride is an autoantigen
CD1a protein overexpression did not produce adequate lipid yield for complex separation
approaches needed to identify the antigenic substances within eluents. Therefore, we
diverted from the goal of assessing only natural cellular molecules and assembled a panel of
synthetic or purified lipid standards that approximated or matched the structures of eluted
natural compounds (Fig. 3b) or known antigens, such as sulfatide, PI and PE. Among
diverse glycolipids, phospholipids, sulfolipids and sphingolipids tested, we observed
stimulatory responses only to synthetic triacylglyceride (TAG) with C16:1 fatty acids,
defining this molecule as an autoantigen for CD1a (Fig. 3d). This finding was surprising
because TAG lacks a bulky or polar headgroup, whereas most or all previously known
antigens carry carbohydrate, phosphate or other rigid and polar or charged hydrophilic
groups, which interact with TCRs. Many glycolipids or phospholipids, including
sphingomyelin and phosphatidylcholine, strongly inhibited the baseline T cell response to
CD1a (Fig. 3d). This inhibition likely reflected lipids binding to CD1a rather than non-
specific effects on T cells, because excess lipid is washed prior to adding T cells. Thus,
naturally occurring CD1a ligands, especially polar lipids with charged or large carbohydrate
groups are not merely ignored, but instead act as antagonists that inhibit autoreactivity of
BC2.
Differential autoreactivity of human tissues
In contrast to the ubiquitous expression on MHC class I, CD1a is only expressed on tissue
resident DCs and is constitutively expressed at extremely high density on epidermal
LCs29,30. This restricted tissue distribution suggests a plausible means of restricting
autoreactive T cell activation based on physical separation of T cells and CD1a-expressing
APCs, as proposed recently2,5. The CD1a reconstitution system allowed testing of the
segregation hypothesis by detecting T cell responses to lipid extracts of various tissues and
type-specific cells. Lipid extracts made with chloroform/methanol from PBMC, K562 cells,
transformed B cells (C1R), myeloid cells (THP-1), and thyroid tissue failed to detectably
activate BC2 and usually showed dose-dependent inhibition below baseline activation
thresholds (Fig. 4a). However, lipid extracts of human epidermis activated BC2 in a dose-
dependent manner. Our initial screens of purified lipids suggested that BC2 responds to
synthetic triacylglycerides (TAG), and the human epidermis is highly enriched in TAG31.
Therefore, we hypothesized that the relatively selective response to skin might be mediated
by this tissue’s natural enrichment for TAG or related apolar lipids.
Normal phase silica thin layer chromatography (TLC) separates lipids based on polarity, so
hydrophobic lipids show higher retention factors (Rf)32. As expected, the TLC analysis of
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ttissue extracts showed that the profile of lipids from epidermis was markedly skewed
towards apolar lipids (Fig. 4b). As compared to other cell types, epidermis contained more
intense spots matching TAG standards and relatively less intense spots matching PC and
SM, which acted as T cell antagonists when tested as purified molecules (Fig. 3d, 4b).
We next tested whether the strong activation of BC2 by epidermis resulted from its
relatively high production of the unusually hydrophobic lipids. Therefore, we extracted
epidermis with a non-polar solvent, pure chloroform. As compared to extracts made with a
mixture of chloroform and methanol, TLC showed that the chloroform-extracted lipid
profile skewed towards more hydrophobic lipids, including TAG, cholesterol esters and wax
esters (Fig. 4b). Indeed, extracts made with pure chloroform showed enhanced BC2
activation by epidermal lipids from all three human donors tested (Fig. 4c). Whereas
chloroform and methanol extracts of K562, THP-1 and thyroid tissues were inhibitory,
chloroform extraction of the same tissues yielded extracts with net T cell activating effects.
Thus, different human tissues have differing antigenic potency, which is directly correlated
with the ratio of apolar to polar lipids present. It is notable that epidermis shows the highest
degree of antigenicity, because human skin is where CD1a+ epidermal LCs are localized and
is enriched for CD1a autoreactive T cells2.
Identification of endogenous cellular autoantigens
Building on identification of synthetic TAG as an autoantigen (Fig. 3d) and the correlation
of TAG content with the antigenic potency of tissues (Fig. 4), we sought to directly purify
the natural autoantigen(s) from epidermis. Using a solvent system that separates highly
apolar lipids32, preparative TLC plates were sprayed with water to visualize the most
abundant lipid bands (0, 1, 2, 3, 4). The silica between each band (0-1, 1–2, 2–3, 3–4, 4+)
was scraped in attempt to recover lipids produced at lower concentrations. We preserved a
slice of the plate for charring to reveal the location of natural skin lipids in comparison to
authentic standards (Fig. 5a). As predicted, analysis of epidermal lipids showed a T cell
response to band 3, which comigrated with a TAG standard. Thus, natural (Fig. 5b) and
synthetic TAGs (Fig. 3d) are CD1a autoantigens.
Patterns of autoantigen recognition in tissues
Prior efforts to identify antigens that activate one T cell clone typically yield a single kind of
stimulatory molecule, recognized without cross-reactivity to other antigens33,34. Therefore,
we were surprised that BC2 was activated by several epidermal lipids with differing
retention factors (Rfs) and chemical structures. For example, BC2 was activated by lipids in
band 2, which comigrated with a free fatty acid standard (Fig 5b) and was demonstrated to
contain free fatty acids by MS (Supplementary Fig. 4a). Also, fraction 3–4 was highly
stimulatory, and comparison with standards demonstrated comigration with TAG or wax
ester standards or both. MS analysis detected triglycerides in fraction 3 and fraction 3–4, and
cholesterol esters were detected in fraction 4 (Supplementary Fig. 4b-d). Responses from
purified epidermal extracts were compared to synthetic or natural standards to clarify the
role of wax esters or cholesterol esters in stimulating the response and to evaluate the
possibility that antigenicity resulted from trace contaminants in natural lipid samples.
Analysis of synthetic molecules agreed with the results obtained from natural lipids: both
showed that TAGs, wax esters and free fatty acids are autoantigens (Fig. 5b). Thus, several
structurally related apolar antigens are produced in human epidermis. However, T cell
responses to lipid structures were not extremely promiscuous: T cells did not recognize other
equivalently hydrophobic molecules, such as cholesterol or cholesterol esters (Fig. 5b), or
self lipids with hydrophilic head groups (Fig. 3b). Instead, T cells recognized three highly
apolar classes of skin lipids, wax esters, TAG and fatty acids.
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tSqualene is a sebaceous autoantigen
Skin repels microbes and retains water by creating surface barriers comprised of unusually
hydrophobic lipids. Therefore, further studies sought to explain the high antigenicity of skin
by pinpointing the source of antigenic lipids, and were guided by published evidence
showing that apolar lipids naturally concentrate as extracellular lipids present in the stratum
corneum and sebum31,35,36. Sebum is a natural mixture of apolar oils and waxy substances
that are normally sequestered in sebaceous glands, and are therefore not directly accessible
to epidermal compartments or CD1a+ Langerhans cells. Sebum is secreted through hair
follicle or sweat glands, where it normally coats the outermost skin surface. Using tissue
microdissection to capture sebaceous glands (Fig. 6a), we analyzed the lipid content and
antigenicity of sebum. In agreement with prior reports31,36, the lipid profile was strongly
skewed toward hydrophobic lipids, with enrichment of TAG and wax esters. Also sebum is
highly enriched in the apolar terpene, squalene (Fig. 6a)31. Human sebum from
microdissected glands, as well as pure synthetic squalene, strongly activated BC2 (Fig. 6b).
Squalene is an unsubstituted terpene lipid that lacks all polar functional groups, so
identification of this antigen provides evidence for T cell activation by a compound with
extreme apolarity.
Headgroups block T cell activation
Crystal structures of CD1-lipid complexes show that lipid antigen recognition typically
occurs by TCR interaction with charged or polar elements of amphipathic lipids14,18. In
contrast, fatty acids (C16), wax esters (C36), triacylglycerides (C51) and squalene (C30)
lacked highly polar head groups. Also, lipids identified here were cross-reactively
recognized despite large differences in size. The observed patterns of cross-reactivity might
be explained by a simple model that T cell activation occurs when CD1a is occupied by
small hydrophobic antigens that are nested within the groove. Recognition does not require
direct TCR contact with the antigen’s headgroup, nor highly specific positioning of the
antigen for TCR interaction. Instead such nested apolar lipids might affect CD1a
conformation from an internal position or cause unloading of lipids whose bulky headgroups
block the TCR approach to CD1a.
Building on initial results suggesting that certain lipid ligands of CD1a inhibit autoreactivity
(Fig. 3d), we undertook more detailed studies to test the functions of headless and headed
ligands of CD1a (Fig. 7a). First, to confirm that stimulatory lipids bind in the CD1a groove,
we measured the extent to which recognition of squalene, wax ester and fatty acid
recognition is blocked by CD1a pretreatment with DDM and sphingomyelin, which
normally seat within one or two pockets of the CD1a groove 18,37.. In agreement with
studies showing ready exchange of endogenous and exogenous lipids in cell surface CD1
proteins 38, T cell activation was reduced or abolished in a dose dependent fashion when
CD1a proteins were pretreated with increasing DDM or sphingomyelin. These results
suggests exchange of lipopeptides or glycolipids for antigenic apolar lipids, as well as a
specific inhibitory function of headed antigens (Fig. 7b), Further supporting this conclusion,
many examples of CD1a ligands with phosphate, sulfate, carbohydrate, anionic or
zwitterionic headgroups, which failed to activate BC2 in plate bound assays (Fig. 3b), also
inhibited the autoreactivity to CD1a proteins under controlled conditions., Dose dependent
inhibition was observed in all cases when headed ligands were applied to fresh cell-derived
CD1a proteins or CD1a that was pre-stripped with acid (Fig. 7c). Overall, the skin-derived
antigens activated T cells independently of all cofactors normally present in APCs. Antigens
likely functioned through CD1a groove binding in a process that involved exchange of
endogenous antigens with non-stimulatory lipids carrying bulky headgroups, including
certain types of lipids identified here as being normally loaded into CD1a in cells.
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Next we studied lipids with small or absent headgroups, which were compared to lipids with
the same or similar alkyl chains, but were modified to increase or decrease headgroup size
and polarity. For example, fatty acids are partially charged, but the charge is absent in fatty
alcohols or methyl esters. Although free fatty acids show detectable autoreactivity (Fig. 5b,
7d), blocking the carboxylate group by either strategy significantly increased antigenic
potency, providing gain of function (Fig. 7d). The wax ester antigen, which contains a
weakly polar internal ester, can be rendered more polar by adding a glycerol unit to create
diacylglycerol, or by further addition of a phosphate group to create phosphodiacylglycerol.
Activation is reduced when adding internal esters and free alcohol groups, and recognition is
abrogated by a phosphate headgroup (Fig. 7e).
To determine whether the observed pattern of activation by hydrophobic headless lipids was
a more general feature of CD1a-autoreactive T cells, we tested our initially generated T cell
lines for activation by the identified activating ligands for BC2. Although Bgp and BC2
express differing TCRs (Supplementary Fig. 5) both recognized hydrophobic antigens and
showed a similar overall hierarchy of recognition of individual antigens, although responses
by Bgp were weaker (Fig. 7f). The weaker response by Bgp to all antigens may explain why
in the initial screening with cell-derived truncated CD1a protein, we did not observe
activation of this T cell line, even though autoreactivity to full length CD1a on cells is
apparent (Fig. 1). In summary, contrary to previously known CD1 antigens, CD1a
autoantigens are extremely apolar, oily substances, which are recognized based on their lack
of polar head groups.
Discussion
Antigens are typically positioned partly within CD1 or MHC grooves, yet rise up to the
plane of TCR contact, creating a composite surface with that antigen presenting molecule,
which is the TCR epitope12–14. The structural constraints of this type of ternary interaction
correctly predict the observed molecular structures of the known antigens for αβ T cells:
peptides and lipids generally match or exceed the molecular volume of the grooves they
bind. These antigens contain polar atoms that mediate highly specific interactions with
TCRs12–14. In contrast, squalene (C30), wax esters (C36), TAGs (C51) and fatty acids (C16)
largely lack substrates for hydrogen bonding, and they are cross-reactively recognized
despite substantial differences in their size. Notably, squalene, a relatively potent natural
CD1a autoantigen, lacks any chemical basis for hydrogen bonding or charge-charge
interactions with the TCR. The divergence of these newly discovered structures from
previously identified αβ T cell antigens points toward a model for T cell activation whereby
skin oils are recognized based on the antigen creating non-interference of an interaction of
CD1a and the TCR.
A study of CD1d-reactive TCRs shows how autoreactivity can be blocked by addition of
bulky lipid ligands39,40, similar to the inhibitory headed ligands of CD1a identified here.
Also, CD1b binds small hydrophobic ligands wholly within the groove such that there is no
extension to the outside of CD1b, where TCR interaction normally occurs25,41. Here we
show that the natural ligands of CD1a are also small hydrophobic molecules, but unlike
scaffold lipids in the CD1b system, these ligands activate T cells. In contrast to nonamer
peptides or diacylglycerols that are of predictable size and match the volume constraints of
their respective antigen binding groove, stimulatory compounds identified here range from
C16 to C51. These antigens do not match each other in length, nor do they match the volume
of the CD1a (1360 Å3), which is optimal for ~C42 lipids37. These cell free assays do not
allow antigen processing, so the diverse sizes are likely maintained until the activating
event. Therefore, it is unlikely that the T cell activation is mediated through a single type of
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thomogenous seating of antigens within the CD1a groove, as is typical of known antigens.
TAGs somewhat exceed the expected volume of the CD1a groove (C42), so might be
recognized through conformational adaptation of CD1a, or the lipid might protrude through
the F’ portal, as occurs for cardiolipin in CD1d42. Specifically, human CD1a has a notch in
the lateral margin of the F’ pocket, which might allow TAG might to escape laterally
without crossing into the plane of TCR contact18.
Two non-exclusive models are that the apolar antigens stabilize the groove, or that they
displace inhibitory ligands. There is evidence that internally positioned lipids alter the outer
CD1 surfaces3843. The loss of BC2 response after acid-stripping of CD1a proteins suggests
that this mechanism is active. However, the dominant mechanism seems to be that apolar
antigens displace CD1a ligands with bulky or charged headgroups, which would otherwise
interfere with CD1a-TCR contact. Supporting noninterference, cellular CD1a proteins bind
many ligands with large headgroups, and certain of these headed ligands block
autoreactivity to CD1a. CD1a autoreactive T cell activation does not result from one potent
agonist, but rather from the ratio of apolar to polar antigens bound to a cohort of CD1a
proteins, so the mechanism is more like a rheostat than an on-off switch.
Skin oils represent natural tissue-specific autoantigens. The lipid profile of most tissues is
dominated by membrane phospholipids and sphingolipids. Although TAG, fatty acids,
squalene can be found in all cells, their extracellular accumulation is largely restricted to
human sebaceous glands and cornified epithelia, which are also the locations where unusual
wax esters are produced in large quantity31. Thus, lipid autoantigens are spatially distributed
within defined extracellular subcompartments of the skin. CD1a expression is likewise
largely restricted to epidermal LCs. These observations suggest a near neighbor model in
which constitutive activation of T cells occurs. Trauma, infection or other barrier breaches
could transfer surface skin oils to deeper layers, promoting CD1a autoreactive T cell
response, including epithelial repair mechanisms associated with IL-222,5.
Discovery of the antigenic properties of skin lipids provides candidate mechanisms by
which alterations in lipid content might influence disease. For example, atopic dermatitis
and psoriasis are associated with changes in ceramide or other skin lipid composition44,45,
and treatments to alleviate symptoms include ointments containing lipids that are shown
here to affect T cell response46. Also, T cell response to hydrophobic components of oils
provides a candidate mechanism for understanding the action of hydrophobic skin contact
sensitizers, which activate T cells but do so by unknown mechanisms. Finally, squalene is a
major component of two adjuvants, MF59 and AS03, which are used in influenza vaccines
in Europe, but whose mechanisms are not fully known47. Thus, CD1a antigen presentation
represents a new candidate mechanism for adjuvancy.
On-Methods
Reagents
Lipid standards were purchased from commercial sources. Cholesterol (catalog#: C8667),
cholesterol ester (catalog#: C6072), Lauryl palmitoleate (wax ester, catalog#: P1642),
triacylglycerol (TAG, glycerol trioleate, catalog#: T7140; glycerol tripalmitoleate, catalog#:
T2630), palmitoleic acid (fatty acid, catalog#: P9417), palmitoleyl alcohol (fatty alcohol,
catalog#: P1547), methyl palmitoleate (fatty methyl ester, catalog#: P9667), squalene
(catalog#: S3626), monosialoganglioside (GM3, catalog#: G5642) were purchased from
Sigma-Aldrich. C18 Ceramide (Cer, catalog#: 860518), C16 β-D-glucosyl ceramide (Glu-
cer, catalog#: 860539), C24 β-D-lactosyl ceramide (Lac-cer, catalog#: 860577),
phosphatidylcholine (PC, catalog#: 770365), Lyso-PC (LPC, catalog#: 855810),
phosphatidylinositol (PI, catalog#: 850144), phosphatidylglycerol (PG, catalog#: 840503),
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tphosphatidylethanolamine (PE, catalog#: 850757), phosphatidylserine (PS, catalog#:
840032), phosphatidic acid (PA, catalog#: 840857), sphingomyelin (SM, catalog#: 860584),
1-palmitoyl-2-oleoyl-sn-glycerol (DAG, catalog#: 800815) were purchased from Avanti
polar lipids. Sulfatide (catalog#:1049), Ceramide trihexosides (Gb3, catalog#: 1067), and
Globotetrahexosylceramide (Gb4, catalog#: 1068) were purchased from Matreya. Oleyl
palmitoleate (wax ester, catalog#: WE1404) and Oleyl oleate (wax ester, catalog#: WE1405)
were purchased from Nu-Chek.
Cellular assays
CD1a autoreactive T cell lines cell cultures were co-cultured with APCs (mock-transfected
K562 cells, CD1-transfected K562 cells) for 24 h and supernatant was analyzed for IL-2, by
HT-2 bioassay or IFN-γ ELISA. For blocking experiments, CD1-transfected K562 cells
were preincubated for 1 h at 37 °C with blocking antibody to the corresponding CD1
molecule, including OKT-6 (anti-CD1a), BCD1b3.1 (anti-CD1b), F10/21A3 (anti-CD1c),
CD1d42 (anti-CD1d), and or P3 (control IgG) (10 μg/ml) before adding T cells.
Recombinant CD1 protein and lipid eluates
Soluble biotinylated CD1 proteins was produced in lentivirus-transduced HEK293 cells by
the National Institutes of Health Tetramer Core Facility (Emory University, Atlanta, GA).
Generation and purification of CD1a protein is similar to CD1b protein, which has been
described previously 16. CD1 and control proteins (MHC-I) were magnetic capture by
streptavidin Dynabeads (Invitrogen), immobilized proteins were washed three times with
PBS and extracted successively with chloroform/methanol (1:2, and 2:1). Elutes from
proteins were separated from beads by centrifugation, which were then stored at −20 °C.
Plate binding assay
96-well streptavidin plates (Thermo Scientific) were incubated for 24 h at room temperature
with 0.5 μg of CD1a protein and 125 ng anti-CD11a (AbD Serotec) per well in PBS, pH 7.4.
Plates were then washed with PBS three times (200 μl/well) and antigens were sonicated in
PBS for 2 minutes and added to the wells and incubated at room temperature for 24–40
hours. The plates were washed with PBS three times before adding105 T cells in a total
volume of 200 μl of T cell medium per well. The plates were then incubated for 24 h at 37
°C, after which culture supernatants were collected for IFN-γ ELISA analysis (Thermo
Scientific). For the acid strip protocol, after 24 h coating of protein, the plates were washed
with PBS three times followed by citrate buffer (pH 3.4 or indicated pH) wash (200 μl/well,
10 minute incubation twice) and three PBS washes before adding lipid antigens.
Epidermis, sebaceous gland and thyroid gland isolation
Discarded human thyroid tissues were obtained from thyroidectomy specimens resected
from patients with autoimmune thyroiditis with the approval of the Institutional Review
Board of Partners Human Research Committee. Normal human skin samples were obtained
as discarded material after cosmetic surgery under approved protocol of the Institutional
Review Board of Partners Human Research Committee. Occipital scalp samples were
obtained as discarded tissue during hair transplantation surgery, and were designated as
nonhuman subject research under 45 CFR Part 46. We therefore received an Institutional
Review Board exemption at Columbia University to use these materials. Epidermis was
separated from dermis as previously described48 and sebaceous glands were isolated using
tissue microdissection methods.
de Jong et al. Page 9
Nat Immunol. Author manuscript; available in PMC 2014 August 01.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tLipid extraction
For cells, culture media was removed and cells were washed with PBS twice. Cell pellets
were extracted successively with chloroform/methanol (1:2 and 2:1) for 2 hours.
Supernatants from two extractions were combined and dried under nitrogen gas. Lipids were
weighted and stored in Chloroform/methanol at −20 °C. Lipid extraction from epidermis and
thyroid tissues was similar procedure as described above except that the samples were
homogenized before solvent extraction. Alternatively, samples were extracted with
chloroform only.
Lipid purification by Thin Layer Chromatography
Silica-coated glass TLC plates (10×20 cm or 20×20 cm, Scientific Adsorbents Incorporated,
GA) were used for analytical or preparative lipid separation. Plates were pre-cleared in
chloroform/methanol/water (60/30/6, V/V/V) to remove contaminants on the plates. The
lipids extracts (100 μg) were developed with a single (hexane/diethyl ether/acetic acid
(70/30/1, V/V/V)32, dual (1st: chloroform/methanol/water (60/35/8, V/V/V) 60% height
from the origin, and 2nd: hexane/diethyl ether/acetic acid (70/30/1, V/V/V) to the top)32, or
triple solvent system (1st: n-hexane/benzene (50/50, V/V) to the top, 2nd: chloroform/
methanol/water (60/16/2, V/V/V) to 5 cm from the origin, 3rd: hexane/diethyl ether/acetic
acid (80/20/10, V/V/V) to 12 cm from the origin) (method modified from 49). To visualize
the spots, plates were sprayed with a solution of 3% (w/v) of cupric acetate in 8% (V/V) of
phosphoric acid, followed by heating at 150 °C for 20–30 min. Chloroform extracted skin
lipids (4 mg) were loaded on a 20×20 TLC plate as a 10 cm-band and 25 μg of lipid extracts
were spotted on the same plate for later charring. After the plate was developed in the
solvent system of hexane/diethyl ether/acetic acid (70/30/1, V/V/V), the plate was separated
to two pieces. The piece containing 25 μg of material was charred for the reference and
another piece containing 4 mg was scraped according to the reference spots. The intervals
between bands were also scraped. The silica was extracted with two times of chloroform/
methanol (2:1).
Mass spectrometry and identification of self lipids of recombinant CD1a by ESI-MS and
HPLC-MS
For nanoelectrospray analysis, 4 μg of protein was denatured and extracted with 100 μl
methanol, 10 μL of unseparated mixtures were loaded onto an in-house made glass
nanospray tip for both positive- and negative-mode electrospray ionization mass
spectrometry (ESI-MS). The ESI-MS and collision induced dissociation (CID-MS/MS) were
performed on LCQ Advantage or LXQ (Thermo Finnigan, Ringoes, NJ), 2 dimensional ion-
trap mass spectrometers. The spray voltage and capillary temperature were set to 0.8 kV and
200 °C, respectively. Collision energy was 30 – 40 % of maximum and the trapping of
product ions were carried out with a q value of 0.25. HPLC-MS and lipidomics analysis of
CD1a eluted lipids was performed as previously described 25. Briefly, extracted lipid ligands
were analyzed with an Agilent Technologies 6520 Accurate-Mass Q-TOF coupled with an
Agilent 1200 seried HLPC system controlled by MassHunter software as described 28
Expression, refolding and purification of recombinant TCRs
The BC2 TCR was produced following protocols previously described 50. Briefly,
individual α and β chains of the TCR, with an engineered disulfide bond between the TRAC
and TRBC constant domains, were expressed in BL21 E. coli cells as inclusion bodies and
solubilised in 8 M urea buffer containing 10 mM Tris-HCl pH 8, 0.5 mM Na-EDTA, and 1
mM dithiothreitol. The TCR was then refolded in refolding buffer that was comprised of 5M
urea, 100 mM Tris-HCl pH 8, 2 mM Na-EDTA, 400 mM L-Arg-HCl, 0.5 mM oxidized
glutathione and 5 mM reduced glutathione. The refolded solution was dialyzed twice against
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t10 mM Tris-HCl pH 8.0 overnight to allow sufficient buffer exchange. The dialyzed
samples were then purified through DEAE cellulose, size-exclusion and anion exchange
HiTrap Q chromatography approaches. The quality and purity of the samples were analyzed
via SDS-PAGE.
Surface Plasmon resonance
Biotinylated CD1a-endogenous lipid derived from the mammalian expression system
(HEK293 cells as described above) was coupled to research-grade streptavidin-coated chips
to a mass concentration of ~2000 resonance units. Increasing concentrations of the BC2
TCR (0–200 μM) were injected over all flow cells for 30 s at a rate of 5 μl/min at 25 °C on a
Biacore 3000 in 10 mM Tris-HCl pH 8, 150 mM NaCl buffer. The final response was
calculated by subtraction of the response for CD1a-endogenous minus an empty flow cell
containing biotin only. The Rmax value indicated that 9.5% of the CD1aendogenous
complex was reactive against BC2 TCR. The data were fitted to a 1:1 Langmuir binding
model using BIAevaluation version 3.1 software (Biacore AB) and the equilibrium data
analyzed using Prism program for biostatistics, curve fitting and scientific graphing
(GraphPad).
Accession codes
Genbank: TCR α- and β-chains of BC2 and Bgp KF751594, KF751595, KF751596,
KF751597
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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CD1a-dependent activation of T cell lines. (a) IL-2 release by T cell cultures, measured by
HT2 bioassay after 24 h of incubation with K562 cells transfected with CD1a, CD1b, CD1c,
CD1d or empty vector (Mock). (b) IFN-γ was measured by ELISA after 24 h with K562
CD1a cells, which were pre-treated (10 μg/ml) with control IgG (P3) or anti-CD1a (OKT6).
Results are representative of at least 3 experiments, which show the mean of triplicate
measurements ± standard deviation.
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Activation of CD1a-autoreactive T cell line by recombinant CD1a. (a) Schematics of
engineered CD1 molecules show zipper-encoding regions (αZip and βZip) and human B2M
sequences, which are linked by cleavable 2A peptide from Thosea asigna virus (2A-TAV).
Regions cleaved upon maturation (dashed line) and the biotinylation site (BSP85) are
indicated. After depletion by agarose beads with and without streptavidin (Strept), CD1a
was analyzed by polyacrylamide gel electrophoresis and silver staining. (b) CD1a protein
was coated on streptavidin plates and incubated with CD1a-autoreactive T cell lines for 24
hrs. IFN-γ ELISA results were plotted as the fold-increase of IFN-γ production over
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tbackground. (c) Plate-bound CD1a protein was pulsed with DDM, then incubated with BC2
cell line or CD8-2 cell line and incubated for 24 h after which IFN-γ was measured by
ELISA. T cell activation was calculated as percentage of maximal IFN-γ production of
indicated T cell line. (d) Lipids eluted from recombinant CD1a and MHC class I protein
(HLA-B2705) were pulsed onto plate-bound CD1a protein. Activation of BC2 cell line was
measured after 24 h by IFN-γ ELISA. Results are representative of 3 experiments, and
depicted as the mean of triplicate measurements ± standard deviation. (e) Surface Plasmon
Resonance measurements of soluble BC2 TCR and immobilized, cell-derived CD1a
monomers are representative of two experiments and are shown as the mean ± standard error
of the mean.
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Lipid composition of eluate from CD1a protein. (a) Chloroform and methanol eluents were
subject to electrospray ionization-MS in positive mode. Detected compounds:
Phosphatidylcholine (PC), Sphingomyelin (SM), Triacylglycerol (TAG),
Phosphatidylinositol (PI), Trihexosylceramide (TriHexCer), Monosialoganglioside (GM3),
Globotetrahexosylceramide (Gb4) (b) Lipid identifications are summarized with key
identifying fragments shown. Full CID-MS spectra are shown in Supplementary Fig. 2 and
3. (c) CD1a proteins were extracted in chloroform and methanol, loaded into a silica-diol
column and eluted in the normal phase. Individual events are assigned when signal is
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tdetected in two or more replicate runs reproducibly detected within mass (20 ppm) and time
(30 sec) windows. Retention time of all events (1,336) is divided into three retention time
ranges that include lipids with low (n=298), intermediate (n=414) and high (n=624) polarity,
shown in comparison to known benchmark lipids, diacylglycerol (DAG), PI, phosphatidyl
ethanolamine (PE) and sphingomyelin (SM). (d) Purified lipids or CD1a eluates were loaded
onto plate-bound CD1a proteins that had been previously treated with acidic citrate buffer
and tested for activation of BC2. Ceramide (Cer), Glucosylceramide (GluCer),
Lactosylceramide (LacCer), Globotriaosylceramide (Gb3), phosphatidylglycerol (PG),
phosphatidylserine (PS), phosphatidic acid (PA). Results are representative of at least 3
experiments, and depicted as the mean of triplicate measurements ± standard deviation.
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Non-polar lipid extracts activate CD1a-autoreactive T cell line. (a) Lipids extracted from
different cell types or tissues in chloroform (CHCl3) and methanol (MeOH) were pulsed
onto recombinant plate-bound CD1a proteins leading to activation of BC2. (b) Lipids (100
μg) extracted with CHCl3: MeOH (2:1, V:V) or CHCl3 alone were analyzed by thin layer
chromatography, compared to lipid standards and visualized by charring. Glucosylceramide
(GluCer), fatty acids (FA), waxester (WE), cholesterol ester (CE). (c,d) Lipids extracted
from epidermis (c) or other tissues (d) using CHCl3: MeOH (2:1, V:V) or CHCl3 alone (d)
were pulsed on recombinant plate-bound CD1a previously stripped with acidic citrate
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tbuffer. Results are representative of 3 experiments, and depicted as the mean of triplicate
measurements ± standard deviation.
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Human epidermis contains multiple lipid antigens. (a) Human epidermis was extracted by
CHCl3, and lipids were separated into 10 fractions (0, 0–1, 1, 1–2, 2, 2–3, 3, 3–4, 4, 4+) by
normal phase preparative TLC in comparison to the named standards. IFN-γ was measured
by ELISA in supernatants of BC2 T cell line incubated with plate-bound CD1a loaded with
dilutions of TLC extracted lipid fractions (b) Epidermal or purified synthetic lipids were
loaded into citrate buffer stripped CD1a proteins and IFN-γ release by BC2 was measured
by ELISA. Wax ester (WE), fatty acid (FA), triacylglycerol (TAG). Results are
representative of at least 3 experiments, and depicted as the mean of triplicate measurements
± standard deviation.
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Human sebaceous gland contains headless CD1a lipid antigens. (a) Sebaceous glands were
microdissected from human occipital scalp tissue and lipids were isolated by chloroform
extraction and analyzed by TLC. (b) Sebaceous gland lipids or synthetic squalene were
loaded onto citrate buffer stripped, plate-bound CD1a proteins and tested for activation of
BC2 by IFN-γ ELISA. Results are representative of 3 experiments, and depicted as the mean
of triplicate measurements ± standard deviation.
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Hydrophilic head groups block CD1a antigen recognition. (a) Structures of identified
activating and inhibitory lipids. Lysophosphatidylcholine (LPC) (b) CD1a protein was
incubated with the indicated DDM or sphingomyelin concentration before squalene (50
μM), wax ester (50 μM) or fatty acid (50 μM) was added. After 24 h coincubation followed
by washing, BC2 was added and IFN-γ release was measured by ELISA. (c,d,e) Indicated
lipids were pulsed onto plate-bound CD1a protein. Activation of BC2 was measured after 24
h in the supernatant by IFN-γ ELISA. (f) CD1a-autoreactive T cell line, Bgp, was tested for
activation by the identified lipid antigens loaded onto plate-bound CD1a. IFN-γ was
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tmeasured in the supernatant by ELISA. Results are representative of 3 experiments, and
depicted as the mean of triplicate measurements ± standard deviation.
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